Rigel Pharmaceuticals





Ebitda تغيير تاريخ
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Celldex Therapeutics USD -72.79M 9.81M 2025-09
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 7.88B 378.1M 2025-09
Halozyme Therapeutics USD 248.25M 22.74M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 20.9M 61.44M 2025-06
MacroGenics USD 21.95M 55.39M 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Veracyte USD 39.73M 3.96M 2025-09


Rigel Pharmaceuticals - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.